Home › Trial NCT03090139
Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
- Trial IDNCT03090139
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorTakeda
- Enrollment1731
- Start date2017-03-28
- ConditionsColitis, Ulcerative · Crohn Disease · Inflammatory Bowel Diseases
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.